Beads for Research | ProMab
Developing lisocabtagene maraleucel chimeric antigen receptor T-cell manufacturing for improved process, product quality and consistency across CD19+ hematologic indications - Cytotherapy
Positive Selection of Mouse B Cells from Single-cell Suspensions of Spleen | Biocompare.com Kit/Reagent Review
Multiplexing single cell measurement of CAR-T cells in microchambers. a... | Download Scientific Diagram
A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL: Molecular Therapy
CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial | Nature Medicine
Anti-CD28 stimulation of CD19-chimeric antigen receptors (CAR) T... | Download Scientific Diagram
Dynabeads™ CD19 Pan B
Establishing CD19 B-cell reference control materials for comparable and quantitative cytometric expression analysis | PLOS ONE
Human CD19 Magnetic Beads MS005 | Proteintech
Phospho-CD19 (Tyr531) Antibody | Cell Signaling Technology
Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies | Hematology, Transfusion and Cell Therapy
CD19 Positive Cell Isolation Kit
Magnetic selection for consistent cellular starting material in autologous cell therapy manufacture
CD19 CAR antigen engagement mechanisms and affinity tuning | Science Immunology
Frontiers | Cytokines induced memory-like NK cells engineered to express CD19 CAR exhibit enhanced responses against B cell malignancies
Selective B cell depletion upon intravenous infusion of replication-incompetent anti-CD19 CAR lentivirus: Molecular Therapy Methods & Clinical Development
Human CD19 Separation Beads | Biocompare.com Kit/Reagent Review
MojoSort Human CD19 Selection Kit
The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies:a meta-analysis | BMC Cancer | Full Text
Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies - ScienceDirect
The QCM frequency shifts of the main steps for the CD19 immobilization... | Download Scientific Diagram
Simplified process for the production of anti–CD19-CAR–engineered T cells - Cytotherapy
CD19：a validated therapeutic target for B-cell malignancies - ACROBiosystems
